Loading company…
Proteon Pharmaceuticals develops bacteriophage-based products that treat bacterial infections in livestock and fish.
Proteon Pharmaceuticals S.A. develops bacteriophage-based products for livestock and aquaculture, aiming to improve animal health and reduce reliance on antibiotics. Its products serve farms and aquaculture firms in Europe, South America, and parts of Asia. Founded in 2005 by Jaroslaw Dastych in Lodz, Poland, the company is at the Series A stage. In August 2021 it raised EUR 21 million, co-led by Aqua-Spark, with participation from Nutreco and the Polish Development Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in